| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28627059e1e1bdd2890ef9b952b82b8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3aeb5e606c1fb1a2ff49eb8ab418b01a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24430c627c7e011dc7560cb085ee51b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f0666ada7b158089d3a4fa378fb0aa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e559743173473475142b7bd8a978298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_488ab6a2c22239841681b2b8183b901b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e23a4c9cd982ccdb6082585045b94b7a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate |
2009-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cdcd4a3b6c4f3d96a05eec1ebb50cbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7575b7e7874ada2c9e163a3e012b837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb70c8acd345066137f55bfbd983a872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d05b4fb1d7c40d7fd9d5ab66703987fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3523100bbcc039b6d1dbdace6b4010e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_473bbe063606a51f6a8f6163e3e2de24 |
| publicationDate |
2009-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009134053-A2 |
| titleOfInvention |
Pharmaceutical composition containing thiazide-based compound with controlled release and angiotensin-ii-receptor blocker |
| abstract |
The present invention relates to a pharmaceutical composition in which release of a thiazide-based compound and angiotensin-II-receptor blocker is controlled, and to a combination preparation technique for the same. More particularly, the present invention relates to a preparation technique capable of maximizing pharmacological and clinical blood pressure control effects and complication preventive effects and significantly reducing side effects by administrating a release-controlled combination preparation rather than administrating a single preparation of thiazide-based compound and a single preparation of angiotensin-II-receptor blocker at the same time. |
| priorityDate |
2008-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |